Cancer is a leading cause of mortality and morbidity worldwide and conventional chemotherapy frequently induce irreversible adverse effects in patients. Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect of both paclitaxel (PTX) and oxaliplatin (OXA) chemotherapies, affecting approximately 30-50% of patients. As cancer survival rates have improved, the efforts of scientific community to develop new strategies for preventing CIPN are also growing.
View Article and Find Full Text PDFObjectives: To evaluate the efficacy of different methods of interfacial elastic compression and their association with obesity and chronic venous insufficiency (CVI).
Methods: Forty legs with vascular disease and 40 control legs were analyzed. Four different methods of elastic compression were applied and interface pressure was measured.
Comp Biochem Physiol C Toxicol Pharmacol
January 2025
Copper excess has been tested as an anticancer therapy, due to its properties to generate oxidative stress resulting in tumoral cell death. Thus, this study aimed to evaluate the impact of copper excess on oxidative stress and antioxidant responses in glioma cells, establishing the antioxidant system as a target of copper toxicity in tumoral cells. C6 and U-87 MG cells were exposed to CuSO (0-600 μM) for 24-48 h.
View Article and Find Full Text PDFMol Neurobiol
July 2023
J Toxicol Environ Health A
February 2020
Regul Toxicol Pharmacol
June 2019
CNS Neurosci Ther
August 2017
J Cell Commun Signal
September 2017
Neurochem Res
February 2016